RYU; Hyung Won

Patent Applications and Registrations

Patent applications and USPTO patent grants for RYU; Hyung Won.The latest application filed is for "composition for prevention or treatment of cardiovascular and metabolic disease comprising noranhydroicaritin".

Company Profile

3.12.15

RYU; Hyung Won - Daejeon KR
Ryu; Hyung Won - Gyeongsangnam-do N/A KR
Ryu; Hyung Won - Masan KR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Composition For Prevention Or Treatment Of Cardiovascular And Metabolic Disease Comprising Noranhydroicaritin App 20220151979 - KIM; Hyo-Soo ; et al.	2022-05-19
Pharmaceutical composition comprising Pistacia weinmannifolia extract, fraction of same or compound separated from same for preventing or treating chronic obstructive pulmonary disease (COPD) Grant 10,751,378 - Oh , et al. A	2020-08-25
Pharmaceutical composition for preventing or treating asthma comprising Pistacia weinmannifolia J. Poiss. ex Franch extract or fraction thereof Grant 10,413,579 - Ahn , et al. Sept	2019-09-17
Method for treating neuroinflammation with a pharmaceutical composition containing Portulaca grandiflora hook. extract or fraction thereof as active ingredient Grant 10,406,187 - Jang , et al. Sept	2019-09-10
Pharmaceutical composition for preventing and treating chronic obstructive lung disease containing, as active ingredient, Magnoliae flos extract, fraction, or active fraction thereof Grant 10,376,553 - Oh , et al. A	2019-08-13
Pharmaceutical Composition For Preventing And Treating Chronic Obstructive Lung Disease Containing, As Active Ingredient, Magnoliae Flos Extract, Fraction, Or Active Fraction Thereof App 20180353561 - OH; Sei-Ryang ; et al.	2018-12-13
Composition For Skin Whitening Comprising Beta-mangostin As Effective Ingredient App 20180256486 - KIM; Kwang Dong ; et al.	2018-09-13
2-phenylbenzofuran derivatives, method for preparing the same and use of the same for treating inflammatory disease Grant 10,053,443 - Lee , et al. August 21, 2	2018-08-21
Pharmaceutical Composition Containing Portulaca Grandiflora Hook. Extract Or Fraction Thereof As Active Ingredient For Preventing Or Treating Neuroinflammation Or Neuro-degenerative Diseases App 20180125903 - JANG; Choon Gon ; et al.	2018-05-10
A novel compound (KS-513) isolated from Pseudolysimachion rotundum var. subintegrum, the composition comprising the same preventing or treating allergic disease, inflammatory disease, asthma or chronic obstructive pulmonary disease and the use thereof App 20180105548 - LEE; Yongnam ; et al.	2018-04-19
Composition containing lignan compound as active ingredient for preventing or treating cancer Grant 9,820,963 - Oh , et al. November 21, 2	2017-11-21
Compound isolated from Pseudolysimachion rotundum var. subintegrum, the composition comprising the same for treating allergic disease, inflammatory disease, asthma or chronic obstructive pulmonary disease and the use thereof App 20170217982 - LEE; Yongnam ; et al.	2017-08-03
Pharmaceutical Composition For Preventing Or Treating Asthma Comprising Pistacia Weinmannifolia J. Poiss. Ex Franch Extract Or Fraction Thereof App 20170173095 - Ahn; Kyung Seop ; et al.	2017-06-22
2-phenylbenzofuran derivatives, method for preparing the same and use of the same for treating inflammatory disease App 20170174645 - LEE; Kyeong ; et al.	2017-06-22
Pharmaceutical Composition Comprising Pistacia Weinmannifolia Extract, Fraction Of Same Or Compound Separated From Same For Preventing Or Treating Chronic Obstructive Pulmonary Disease (copd) App 20170035822 - OH; Sei Ryang ; et al.	2017-02-09
Novel 2-phenylbenzofuran Derivative Or Pharmaceutically Acceptable Salt Thereof, Production Method For Same And Pharmaceutical Composition For Preventing Or Treating Inflammatory Disease Comprising Same As Active Ingredient App 20160332980 - LEE; Kyeong ; et al.	2016-11-17
Composition Containing Lignan Compound As Active Ingredient For Preventing Or Treating Cancer App 20160228402 - OH; Sei Ryang ; et al.	2016-08-11
Method for screening anti-cancer compounds inhibiting function of TM4SF5 and anti-cancer composition containing chalcone compounds Grant 9,072,698 - Park , et al. July 7, 2	2015-07-07
Preparation method of apigenin and dehydrosilybin mixture using radiation Grant 8,658,000 - Jin , et al. February 25, 2	2014-02-25
Preparation Method Of Chromenone Derivatives Using Radiation App 20130146440 - JIN; Chang Hyun ; et al.	2013-06-13
Method for screening anti-cancer compounds inhibiting function of TM4SF5 and anti-cancer composition containing chalcone compounds Grant 8,445,722 - Park , et al. May 21, 2	2013-05-21
Method For Screening Anti-cancer Compounds Inhibiting Function Of Tm4sf5 And Anti-cancer Composition Containing Chalcone Compounds App 20120282619 - Park; Ki Hun ; et al.	2012-11-08
Chalcone derivatives, pharmaceutically acceptable salt, method for preparation and uses thereof Grant 7,851,654 - Park , et al. December 14, 2	2010-12-14
Method For Screening Anti-cancer Compounds Inhibiting Function Of Tm4sf5 And Anti-cancer Composition Containing Chalcone Compounds App 20100068730 - PARK; Ki Hun ; et al.	2010-03-18
Novel Chalcone Derivatives, Pharmaceutically Acceptable Salt, Method for Preparation and Uses Thereof App 20090252694 - Park; Ki Hun ; et al.	2009-10-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.